Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation

This study investigates whether pulsed field ablation (PFA) is a more effective initial treatment for patients with persistent atrial fibrillation compared to traditional antiarrhythmic drug therapy. The results indicate that PFA significantly reduces the risk of recurrence of atrial arrhythmias at 12 months, with a treatment success rate of 56% in the PFA group versus 30% in the antiarrhythmic-drug group. Additionally, the safety profile of PFA was comparable to that of antiarrhythmic drugs, suggesting PFA may be a preferable first-line therapy.